Open original FDA record ↗Recall record
- FDA identifier
- Z-2274-2025
- Company in FDA record
- Nuclein LLC
- FDA classification date
- Aug 6, 2025
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Due to manufacturing error, assay test may result in missed diagnosis or delay of treatment. (Potential false negative result)
Source facts
- Action
- On June 25, 2025, Nuclein, LLC issued a Urgent: Medical Device Recall notification to affected customers. On July 8, 2025 an updated notification was issued via E.Mail. a. Review your inventory of DASH SARS-CoV-2 & Flu A/B Tests to confirm the quantity of Lot BB02 or BB03 that you have remaining. b. Suspend the use and quarantine the affected lot of DASH SARS-CoV-2 & Flu A/B Tests; Nuclein will replace any unused affected product. c. Review all results of the product lots detailed in Section 6, below, to identify potentially erroneous diagnosis, except in those cases where alternative confirmation was obtained. d. Forward this information to all individuals and departments within your organization using the product information detailed in Section 6. If you are not the end user, forward this notice to the product end user. e. Complete the Acknowledgement and Receipt Form below and either email the completed form to customersupport@nuclein.com or mail to the address identified in the Acknowledgement and Receipt Form. f. Return the affected tests that you have remaining; Nuclein Customer Support will follow up with you on the details of returning or destroying the affected product.
- Initiated
- 2025-06-25
- Root cause
- Process control
- Distribution
- US distribution to: Florida, New York, Texas, and West Virginia
- Recall number
- Z-2274-2025
- Recall status
- Open, Classified
- CDRH record ID
- 214936
- FDA classified
- 2025-08-06
- Recall event number
- 97228